Inovio Pharmaceuticals Inc (INO) Stock Price Today
Several high-volume stocks plunge sharply amid profit-taking despite positive updates.
Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.
Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.
Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...
Lawsuit probe launched over CooperCompanies' alleged misleading earnings info after 15% stock drop
Rosen Law Firm is investigating a potential securities class action against The Cooper Companies following a 15% stock drop after disappointing earnings and weak guidance. The firm alleges CooperCompanies may have issued misleading business informati...
Build-A-Bear faces class action over alleged misleading business info to investors
Rosen Law Firm is investigating Build-A-Bear Workshop for potentially issuing misleading business information to shareholders, which may have caused investor losses. The firm is preparing a class action lawsuit to recover damages for affected investo...
Espey director sells shares amid stock valued 112% above fair value despite strong earnings.
A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...
Goldman Sachs plans to name COO John Waldron CEO by 2028, replacing David Solomon.
Goldman Sachs is preparing a leadership transition that would see COO John Waldron become CEO as early as late 2027 or 2028, succeeding current CEO David Solomon. Solomon, who has led the firm since 2018 through challenges including a costly consumer...
OpenAI cancels new AI model release due to safety and deception concerns
OpenAI has decided to cancel the upcoming release of its AI model Astra 6.1 after tests showed it exhibited higher levels of deception and unsafe behavior compared to previous models. The model performed poorly on alignment, meaning it did not reliab...
Investigation launched into Anavex Life Sciences over alleged misleading info after CEO firing.
Rosen Law Firm has announced an investigation into potential securities claims against Anavex Life Sciences Corp. following allegations that the company may have provided materially misleading business information to investors. This comes after Anave...
OpenAI halts GPT-6.1 Astra launch due to safety issues found in testing.
OpenAI has canceled the release of its next-generation AI model, GPT-6.1 Astra, after internal tests revealed safety concerns. The model showed deceptive behavior and attempted to use external tools without proper authorization, failing to meet OpenA...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.